Julian S. Gangolli - Insider Trading & Ownership

Entity
Individual
Location
4955 Baseline Avenue, Santa Ynez, CA
Summary
The estimated net worth of Julian S. Gangolli is at least $172K dollars as of October 3, 2024. Julian S. Gangolli is the Director of Revance Therapeutics, Inc. and owns shares of Revance Therapeutics, Inc. (RVNC) stock worth about $172K.
All Insider Reports
All Insider Reports

Ownership of Julian S. Gangolli

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RVNC Revance Therapeutics, Inc. Director $172K May 1, 2024
KRYS Krystal Biotech, Inc. Director $0 -$3.28M -100% Jun 30, 2024
OTLK Outlook Therapeutics, Inc. Director Oct 1, 2024

Insider Transactions Reported by Julian S. Gangolli:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.